The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis.
 
Maeve Aine Lowery
No Relationships to Disclose
 
Laura Williams Goff
Consulting or Advisory Role - Celgene
Research Funding - Amgen; Astellas Pharma; Onyx; Pfizer; Sun Pharma
 
Emmet Jordan
No Relationships to Disclose
 
Rui Wang
No Relationships to Disclose
 
Andrea Grace Bocobo
No Relationships to Disclose
 
Joanne F. Chou
No Relationships to Disclose
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Aduro Biotech; Astellas Pharma (I); Celgene; Celsion (I); Cipla; Exelixis (I); Gilead Sciences; Hexal (I); IntegraGen (I); Jennerex (I); Lilly (I); MedImmune; Merrimack; Novartis (I); Pharmacyclics; Sanofi; Silenseed; Vicus Therapeutics
Research Funding - Celgene (Inst); Clovis Oncology (Inst); Immunomedics (Inst); Incyte (Inst); Momenta Pharmaceuticals (Inst); Myriad Genetics (Inst); OncoMed (Inst); Polaris (Inst); Sanofi (Inst)
 
James J. Harding
No Relationships to Disclose
 
Nancy E. Kemeny
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
Ann Griffin
No Relationships to Disclose
 
Joseph P. McGuire
No Relationships to Disclose
 
Alan P. Venook
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Merck Serono; Roche
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Aduro Biotech (I); Astellas Pharma; AstraZeneca (I); Celgene; Celsion; cipla; Exelixis; IntegraGen; Jennerex; Lilly/ImClone; MedImmune; Novartis; Pharmacyclics (I); Sanofi (I); Silenseed (I); Vicus Therapeutics
Research Funding - Abbott Laboratories (Inst); Amgen (Inst); Bayer (Inst); Exelixis (Inst); Genentech (Inst); Lilly/ImClone (Inst); Novartis (Inst); Polaris (Inst); Roche (Inst); Vicus Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris
 
Robin Kate Kelley
Consulting or Advisory Role - Acceleron Pharma; Lilly
Research Funding - Celgene (Inst); Exelixis (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Tekmira (Inst)